Regulatory oversight on the use of experimental therapies during a pandemic: The case of early access to convalescent plasma therapy in three LMICs
Drug discovery today, 2022-03, Vol.27 (3), p.686 [Peer Reviewed Journal]Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 1359-6446 ;EISSN: 1878-5832 ;DOI: 10.1016/j.drudis.2021.12.002 ;PMID: 34906688
Digital Resources/Online E-Resources